Related Experiment Video
Updated: Aug 21, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Regulation of NF-kappaB by atypical activators and tumour suppressors
1Division of Gene Regulation and Expression, School of Life Sciences, MSI/WTB Complex, Dow Street, University of Dundee, Dundee DD1 5EH, Scotland, UK. n.d.perkins@dundee.ac.uk
Abstract:
The RelA(p65) NF-kappaB (nuclear factor kappaB) subunit is typically thought of as being antiapoptotic and tumour-promoting. However, in our laboratory, we have discovered that RelA can inhibit, rather than induce, antiapoptotic gene expression when activated by certain chemotherapeutic drugs, UV light or through the action of the ARF tumour suppressor. These observations explain why RelA can sometimes facilitate rather than inhibit apoptosis and also exhibits tumour-suppressor characteristics in vivo. A better understanding of these processes and an ability to analyse RelA function in tumours could lead to improved cancer diagnosis, choice of therapy and, ultimately, development of new drugs.
Insights
The RelA(p65) nuclear factor kappaB subunit can inhibit antiapoptotic genes under specific conditions, revealing its novel tumor suppressor roles. This finding challenges the traditional view and offers new avenues for cancer therapy development.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- The RelA(p65) subunit of nuclear factor kappaB (NF-kappaB) is traditionally recognized for its antiapoptotic and tumor-promoting functions.
- This established role has guided cancer research and therapeutic strategies for years.
Purpose of the Study:
- To investigate the unconventional role of RelA(p65) in apoptosis regulation.
- To explore conditions under which RelA(p65) exhibits tumor suppressor characteristics.
Main Methods:
- Activation of RelA(p65) using chemotherapeutic drugs, UV radiation, and the ARF tumor suppressor.
- Analysis of antiapoptotic gene expression in response to RelA(p65) activation.
- In vivo studies to assess tumor suppressor characteristics.
Main Results:
- RelA(p65) activation by specific chemotherapeutic drugs, UV light, or ARF can inhibit, rather than induce, antiapoptotic gene expression.
- These findings provide a mechanistic explanation for instances where RelA(p65) promotes apoptosis.
- Demonstrated in vivo tumor suppressor activities of RelA(p65) under certain conditions.
Conclusions:
- The function of RelA(p65) is context-dependent, capable of both promoting and suppressing tumors.
- Understanding these dual roles is crucial for accurate cancer diagnosis and selecting appropriate therapies.
- Further analysis of RelA function in tumors may lead to novel therapeutic strategies and drug development.
Related Concept Videos
Abnormal Proliferation
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Negative Regulator Molecules
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Co-activators and Co-repressors

